Serum institute CEO expects Omicron-specific vaccine in 6 months: Report Ruchika Sharma17 Aug 2022 11:00 AM ISTNew Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six...
Centre plans to roll out SII qHPV vaccine for girls aged 9-14 years under National Immunization Programme Ruchika Sharma11 Aug 2022 4:30 PM ISTCervical cancer can be prevented by vaccinating girls in the age group of 9-14 years with HPV vaccine, the sources said.
SII conducting research to find vaccine against Monkeypox, says Adar Poonawalla Rahul Verma4 Aug 2022 6:00 PM ISTSerum Institute of India CEO Adar Poonawalla Tuesday said his firm is conducting research to find a vaccine against monkeypox as cases rise in the...
Serum Institute conducting research to find vaccine against monkeypox: Adar Poonawalla Ruchika Sharma3 Aug 2022 5:08 PM ISTMonkeypox typically manifests itself with fever, rash and swollen lymph nodes and may lead to a range of medical complications. It is usually a...
Serum Institute to supply 1 crore qHPV vaccine doses by December: Sources Ruchika Sharma2 Aug 2022 11:34 AM ISTCervical cancer in India ranks as the second most frequent cancer among women aged between 15 and 44 years.
SII to launch QHPV vaccine against cervical cancer Rahul Verma14 July 2022 10:42 AM ISTIndia's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India's (DCGI) approval for...
Covishield demand down under Covax Rahul Verma13 July 2022 3:07 PM ISTAs per a document on the World Health Organization (WHO)- supported global Covid vaccine facility, Serum Institute of India's COVID vaccine...
FIRST: Serum Institute gets DCGI nod for qHPV vaccine against cervical cancer Ruchika Sharma13 July 2022 11:37 AM ISTThe National Technical Advisory Group on Immunisation (NTAGI) had recently also approved the qHPV after reviewing the clinical trial data of the...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine Rahul Verma8 July 2022 5:30 PM ISTThe Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine...
DCGI recommends allowing SII to manufacture, stockpile life-saving qHPV vaccine against cervical cancer Ruchika Sharma7 July 2022 1:30 PM ISTCervical cancer is the second-most frequent type of the disease in India among women aged between 15 and 44 years.
Include Cy-Tb injection in national TB elimination programme: SII urges MoHFW Ruchika Sharma5 July 2022 1:21 PM ISTNew Delhi: Serum Institute has requested the Union health ministry for inclusion of their Cy-Tb injection for detection of Latent-TB in the National...
